Search

Results 61-70 of 71
Publication DateTitleAuthor(s)
24-Aug-2016Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism.Maneechotesuwan, K; Kasetsinsombat, K; Wongkajornsilp, A; Barnes, PJ
10-Jan-2017The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trialsO'Byrne, PM; FitzGerald, JM; Zhong, N; Bateman, E; Barnes, PJ, et al
27-Jun-2014Impaired macrophage phagocytosis of bacteria in severe asthmaLiang, Z; Zhang, Q; Thomas, CMR; Chana, KK; Gibeon, D, et al
26-May-2016CORRIGENDUM: Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)Levy, ML; Dekhuijzen, P; Barnes, PJ; Broeders, M; Corrigan, CJ, et al
4-Oct-2017Mitochondria, telomeres and cell senescence: Implications for lung ageing and diseaseBirch, J; Barnes, PJ; Passos, JF
23-May-2017Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpressionDi Stefano, A; Ricciardolo, FLM; Caramori, G; Adcock, IM; Chung, KF, et al
1-Sep-2018Role of airway glucose in bacterial infections in chronic obstructive pulmonary diseaseTregoning, JS; Mallia, P; Webber, J; Gill, SK; Trujillo-Torralbo, et al
1-Apr-2018Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: association with inflammatory mediators and cellsHashemian, SM; Mortaz, E; Jamaati, H; Bagheri, L; Mohajerani, SA, et al
12-Dec-2018Low-dose budesonide/formoterol counteracts airway inflammation and improves lung function in COPDHakim, A; Khan, Y; Esteban, I; Meah, S; Miller-Larsson, A, et al
11-Dec-2017Quercetin restores corticosteroid sensitivity in cells from patients with chronic obstructive pulmonary disease.Mitani, A; Azam, A; Vuppusetty, C; Ito, K; Mercado, N, et al